METHOD FOR PREVENTING OBESITY IN MEN WITH PARTIAL AGE-CAUSED ANDROGENIC DEFICIENCY (PADAM)

FIELD: medicine, urology, endocrinology. ^ SUBSTANCE: the present innovation deals with decreasing the levels of prolactin, somatotropic hormone (STH), insulin-like growth factor-1 (IGF-1), adrenocorticotropic hormone (ACTH), cortisol, 17beta-estradiol, 5alphadihydrotestosterone, insulin, glucagons,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAZUROV V.I, KARPISHCHENKO A.I, PECHERSKIJ A.V, SEMIGLAZOV V.F, VELIKANOVA L.I
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, urology, endocrinology. ^ SUBSTANCE: the present innovation deals with decreasing the levels of prolactin, somatotropic hormone (STH), insulin-like growth factor-1 (IGF-1), adrenocorticotropic hormone (ACTH), cortisol, 17beta-estradiol, 5alphadihydrotestosterone, insulin, glucagons, glucose in blood plasma to an empty stomach, 1.25(OH)2D3, epidermal growth factor (EGF), factor of tumor necrosis alpha, interleukin 1 alpha, interleukin 1 beta, interleukin 6 due to individual matching the dose of testosterone preparation to normalize luteinizing hormone (LH) levels, those of total testosterone, free testosterone, globulin binding sex hormones, index of free androgens, 5alpha-dihydrotestosterone, 17beta-estradiol and restore impulse LH secretion and total testosterone. The method enables to affect pathogenetic aspects of obesity prophylaxis. ^ EFFECT: higher efficiency of prophylaxis.